Top compounds associated with response to CHFR


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib UHNBreast pan-cancer AAC -0.34 0.2
mRNA CP724714 GDSC1000 pan-cancer AAC 0.041 0.2
mRNA L-685458 CCLE pan-cancer AAC 0.055 0.2
mRNA CAY10603 GDSC1000 pan-cancer AAC 0.036 0.2
mRNA Topotecan CCLE pan-cancer AAC -0.052 0.2
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.042 0.2
mRNA Compound 1541A CTRPv2 pan-cancer AAC 0.046 0.2
mRNA TL-1-85 GDSC1000 pan-cancer AAC 0.036 0.2
mRNA tipifarnib CTRPv2 pan-cancer AAC 0.037 0.2
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.042 0.2
Download CSV